Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet transfusion therapy.

J Aisner

    The Medical Clinics of North America
    |September 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Platelet transfusions effectively treat low platelet counts and bleeding disorders, supporting intensive cancer therapy. Advances in blood banking are expanding platelet availability and transfusion programs for cancer care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
    Same author

    Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.

    Cancer·2001
    Same author

    Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.

    Cancer·2001
    Same author

    High-time chemotherapy or high time for low dose.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
    Same author

    Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
    Same author

    Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Hematology
    • Transfusion Medicine
    • Oncology

    Background:

    • Platelet transfusions are vital for managing thrombocytopenia and platelet dysfunction.
    • Blood component therapy has increased the availability of platelets.
    • Intensified antineoplastic (cancer) therapy necessitates robust platelet support.

    Purpose of the Study:

    • To highlight the established benefits of platelet transfusions.
    • To discuss the evolving landscape of platelet supply and transfusion programs.
    • To emphasize the increasing importance of platelet transfusion services in cancer treatment centers.

    Main Methods:

    • Review of current practices in blood banking and component therapy.
    • Discussion of advancements in platelet procurement and quality control.

    Related Experiment Videos

  • Analysis of the integration of transfusion services into cancer care models.

    • Main Results:

    • Platelet transfusions are proven beneficial for thrombocytopenia and platelet disorders.
    • Modern blood banks can supply platelets, with potential for increased future supply.
    • Development of comprehensive transfusion programs is crucial for advanced cancer therapy.

    Conclusions:

    • Platelet transfusion programs are essential for modern cancer treatment centers.
    • Enhanced platelet supply, storage, donor selection, and quality control are necessary.
    • These programs will become increasingly integral as antineoplastic therapies advance.